ART5803, a First-in-class Precision Medicine to Treat Anti-NMDA Receptor Encephalitis, First-in-human Phase 1 Clinical Safety and Pharmacokinetic Profile

ART5803 - Arialys Therap

Sankalp Gokhale1; Mari Maurer1; April Purcell1; Amanda Singh2; Sanela Bilic2; Martin Jefson1; Peter Flynn1; Mitsuyuki Matsumoto1

Mar 6, 2026